Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Discovery and Optimization of Thienopyrazine RNA-Splicing Modulators for the Treatment of Huntington's Disease.
Journal: Journal of medicinal chemistry
Published: March 17, 2026
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis.
Journal: Journal of medicinal chemistry
Published: May 07, 2024
Showing 1-2 of 2
Last Updated: 09/26/2026